We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Robert Half
RHI
$4.04B
| $6.61M | 0.16% |
160,933
+152,936
| +1,912% | +$6.97M |
|
152
Carvana
CVNA
$47.3B
| $6.6M | 0.16% |
+97,880
| New | +$5.37M |
|
153
Honeywell
HON
$78.3B
| $6.57M | 0.16% |
29,929
+26,548
| +785% | +$5.37M |
|
154
Rivian
RIVN
$24.2B
| $6.49M | 0.16% |
472,156
+58,341
| +14% | +$792K |
|
155
Chewy
CHWY
$9.38B
| $6.48M | 0.16% |
+152,043
| New | +$6.06M |
|
|
VRNA
156
DELISTED
Verona Pharma
VRNA
| $6.47M | 0.16% |
68,356
+57,006
| +502% | +$4.22M |
|
157
Carlisle Companies
CSL
$14.1B
| $6.41M | 0.16% |
17,172
+16,260
| +1,783% | +$6.04M |
|
158
Paychex
PAYX
$42.3B
| $6.38M | 0.16% |
+43,885
| New | +$6.61M |
|
159
Ovintiv
OVV
$16.4B
| $6.38M | 0.16% |
167,728
+156,420
| +1,383% | +$5.74M |
|
160
TJX Companies
TJX
$178B
| $6.34M | 0.16% |
+51,355
| New | +$6.51M |
|
161
Vertiv
VRT
$104B
| $6.17M | 0.15% |
+48,050
| New | +$4.67M |
|
162
IonQ
IONQ
$12.6B
| $6.1M | 0.15% |
+142,050
| New | +$4.76M |
|
163
APA Corp
APA
$12.3B
| $6.1M | 0.15% |
333,685
+252,009
| +309% | +$4.37M |
|
164
Core Scientific
CORZ
$6.63B
| $6.09M | 0.15% |
+356,622
| New | +$3.57M |
|
165
Colgate-Palmolive
CL
$74.2B
| $6.04M | 0.15% |
66,433
+64,042
| +2,678% | +$5.85M |
|
166
Hamilton Lane
HLNE
$3.91B
| $6.03M | 0.15% |
+42,454
| New | +$6.4M |
|
167
McDonald's
MCD
$194B
| $6.03M | 0.15% |
+20,626
| New | +$6.36M |
|
168
Onto Innovation
ONTO
$12B
| $6.02M | 0.15% |
59,608
+25,751
| +76% | +$2.75M |
|
169
MGM Resorts International
MGM
$11.8B
| $6.01M | 0.15% |
+174,888
| New | +$5.55M |
|
170
Scotiabank
BNS
$108B
| $6.01M | 0.15% |
108,750
+101,687
| +1,440% | +$5.18M |
|
171
Murphy USA
MUSA
$11.1B
| $5.99M | 0.15% |
14,726
+12,914
| +713% | +$5.87M |
|
172
MP Materials
MP
$7.35B
| $5.98M | 0.15% |
+179,805
| New | +$4.59M |
|
173
Teleflex
TFX
$5.94B
| $5.98M | 0.15% |
50,541
+7,038
| +16% | +$888K |
|
174
Cooper Companies
COO
$14.1B
| $5.91M | 0.14% |
83,046
+79,933
| +2,568% | +$6.12M |
|
175
Aptiv
APTV
$12.6B
| $5.88M | 0.14% |
86,200
+68,905
| +398% | +$4.27M |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.